Kannalife Sciences

Founded in 2010 by Dean Petkanas and Thoma Kikis, Kannalife Sciences Inc. is a biopharmaceutical company headquartered in Doylestown, Pennsylvania. As a subsidiary of Neuropathix, Inc., Kannalife focuses on developing natural phyto-medical products and next-generation therapeutics targeting inflammation and neurotoxicity. The company holds an exclusive license for the commercialization of the U.S. patent "Cannabinoids as Antioxidants and Neuroprotectants," granted by NIH-OTT, and aims to address significant unmet medical needs through its innovative pipeline.

Notable figures associated with Kannalife include Dr. Tage Honoré, Chairman of the Board of Advisors, and Terrence O. Tormey. The company has achieved significant milestones, such as bolstering its intellectual property portfolio with multiple patents in key European territories. Kannalife's work has had a considerable impact on the pharmaceutical industry, particularly in the realm of cannabinoid-based therapeutics, positioning it as a leader in addressing oxidative and neuro-toxic stresses from various ailments.